Dr. Fernanda De Pinho Silveira, MD

Dr. Silveira practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Silveira's NPI, 1629007851, was assigned on July 1, 2006. Dr. Silveira holds Pennsylvania license MD428856.

Dr. Silveira's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Silveira's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Silveira is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Silveira to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silveira practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Silveira's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Silveira is licensed in Pennsylvania.

CMS data shows 118 Medicare services from Dr. Silveira across 3 procedure codes in 2024, for 78 Medicare patients. Medicare paid $7,866 for them.

CMS counts 78 Medicare patients who saw Dr. Silveira in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 4.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silveira's median patient age at 59, with 38% women.

In 2024, Dr. Silveira wrote 264 Medicare Part D claims for 52 patients. 88% of them were for generic drugs. CMS names the drug for 154 of them, across 8 drugs with 11 or more claims each, at $126,084 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Silveira for performance year 2024, reported as part of a group. Dr. Silveira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silveira as offering telehealth.

CMS Open Payments shows 7 general payments to Dr. Silveira from 5 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 90% of the total. Janssen Research & Development, LLC paid the most, $3,600. It also lists 1 research payment totaling $60 in 2019.